Dr. Cynthia C Su, MD Physical Medicine & Rehabilitation - Pain Medicine Medicare: Not Enrolled in Medicare Practice Location: 1788 Republic Rd, Ste 200, Virginia Beach, VA 23454 Phone: 757-422-2966 Fax: 757-422-4563 |
Douglas Kuo, D.O. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1060 First Colonial Rd, Virginia Beach, VA 23454 Phone: 757-395-2323 |
Nicholas Wheeling Bulleit, LPTA Physical Medicine & Rehabilitation - Neuromuscular Medicine Medicare: Not Enrolled in Medicare Practice Location: 5604a Virginia Beach Blvd Ste 101, Virginia Beach, VA 23462 Phone: 757-455-5000 |
Dr. David Scott Levi, MD Physical Medicine & Rehabilitation - Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 5716 Cleveland St Ste 200, Virginia Beach, VA 23462 Phone: 757-502-8583 Fax: 757-226-9044 |
News Archive
NPS Pharmaceuticals, Inc. (NASDAQ: NPSP), a biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases worldwide, today announced that president and chief executive officer Francois Nader, M.D. has received the Ernst & Young Entrepreneur Of The Year® 2013 Award in the Life Sciences category in New Jersey. Dr. Nader was presented with the award at a special gala event on June 13 at the Hyatt Regency New Brunswick, New Jersey.
A major study from a team of researchers from Weill Cornell Medical College and Massachusetts General Hospital has found that a recent change to HIV-treatment guidelines recommending genetic screening is cost-effective under certain conditions. The new recommendation suggests conducting a genetic screening test prior to prescribing the drug abacavir, one of the preferred first-line drugs for the treatment for HIV-infected adults.
A team of Johns Hopkins Children's Center researchers has discovered that a protein involved in cystic fibrosis also regulates inflammation and cell death in emphysema and may be responsible for other chronic lung diseases.
News outlets tracked the immediate political fallout of the Supreme Court's Burwell v. Hobby Lobby Stores decision.
Novartis Pharmaceuticals Corporation will showcase more than one hundred and sixty presentations on data from its robust oncology portfolio at two key medical congresses this month, demonstrating significant advances for patients with cancers and hematological diseases.
› Verified 3 days ago